We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

QUINENCO:BCSQuinenco S.A. Analysis

Data as of 2026-05-23 - not real-time

CLP 3,973.40

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Quiñenco is trading well beneath its short‑term, intermediate‑term and long‑term simple moving averages, signaling a bearish technical backdrop. RSI sits in the lower‑mid range, hinting at a near‑oversold condition, while the MACD line remains below its signal line, reinforcing bearish momentum. The stock is perched just above a clear support zone, offering a modest cushion against further declines, but faces a sizable resistance barrier ahead.
Fundamentally, the company boasts a price‑to‑earnings multiple that is dramatically lower than the sector average, and a discounted cash‑flow model points to a substantial upside potential. Strong revenue growth, solid cash generation, and a dividend yield that outpaces many peers suggest a resilient earnings base. However, the conglomerate carries a high debt‑to‑equity profile, and the energy‑focused segment is exposed to regulatory and commodity‑price fluctuations. Overall, the blend of deep valuation discount, attractive dividend, and low market beta creates a compelling case for investors with a longer horizon, while short‑term traders should respect the prevailing bearish technical signals.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish technical indicators (price below SMAs, MACD bearish)
  • Proximity to support level limiting immediate downside
  • Attractive dividend yield providing income while waiting for rebound

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant valuation gap versus peers and DCF upside
  • Robust revenue growth and strong cash flow generation
  • Sustainable dividend with moderate payout ratio

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Long‑term undervaluation and low beta indicating defensive profile
  • Consistent dividend payments supporting total return
  • Potential for operational improvements and debt reduction over time

Key Metrics & Analysis

Financial Health

Revenue Growth25.60%
Profit Margin8.58%
P/E Ratio9.7
ROE10.03%
ROA1.54%
Debt/Equity102.69
P/B Ratio0.7
Op. Cash FlowCLP2563.6B
Free Cash FlowCLP1822.0B
Industry P/E21.6

Technical Analysis

TrendBearish
RSI38.6
SupportCLP 3,812.20
ResistanceCLP 4,512.50
MA 20CLP 4,171.73
MA 50CLP 4,291.27
MA 200CLP 4,307.75
MACDBearish
VolumeIncreasing
Fear & Greed Index91.61

Valuation

Fair ValueCLP 30,557.37
Target PriceCLP 5,400.00
Upside/Downside35.90%
GradeUndervalued
TypeGrowth
Dividend Yield3.09%

Risk Assessment

Beta0.25
Volatility35.38%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.